SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-011298
Filing Date
2020-04-24
Accepted
2020-04-24 16:59:51
Documents
1
Period of Report
2020-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12616
  Complete submission text file 0000899243-20-011298.txt   14781
Mailing Address AVE NESTLE 55 CH-1800 VEVEY V8
Business Address AVE NESELE 55, CH-1800 VEVEY V8 01141219241111
NESTLE SA (Reporting) CIK: 0000792990 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37519 | Film No.: 20815826
SIC: 2000 Food and Kindred Products
Office of Manufacturing

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Issuer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address AVENUE NESTLE 55 VEVEY V8 CH-1800
Business Address AVENUE NESTLE 55 VEVEY V8 CH-1800 41-21-924-1111
Societe des Produits Nestle S.A. (Reporting) CIK: 0001803539 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37519 | Film No.: 20815825